Back
AbbVie Stock Price Chart
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.
Buy
73
ABBV
AbbVie
Last Price:
185.15
Seasonality Move:
-0.45%
7 Day Trial
ALL ACCESS PASS
$
7
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing slight buying pressure.
AbbVie Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 176.13 | Buy |
| 20-day SMA: | 171.41 | Buy |
| 50-day SMA: | 167.7 | Buy |
| 200-day SMA: | 162.51 | Buy |
| 8-day EMA: | 177.16 | Buy |
| 20-day EMA: | 173.1 | Buy |
| 50-day EMA: | 169.82 | Buy |
| 200-day EMA: | 163.79 | Buy |
AbbVie Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.25 | Buy |
| Relative Strength Index (14 RSI): | 72.04 | Buy |
| Chaikin Money Flow: | 1989723 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (166.67 - 175.89) | Buy |
| Bollinger Bands (100): | (162.02 - 176.42) | Buy |
AbbVie Technical Analysis
| Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for AbbVie Stock
Is AbbVie Stock a Buy?
- AbbVie share price is 185.16 while ABBV 8-day simple moving average is 176.13, which is a Buy signal.
- The stock price of ABBV is 185.16 while AbbVie 20-day SMA is 171.41, which makes it a Buy.
- AbbVie 50-day simple moving average is 167.70 while ABBV share price is 185.16, making it a Buy technically.
- ABBV stock price is 185.16 and AbbVie 200-day simple moving average is 162.51, creating a Buy signal.
ABBV Technical Analysis vs Fundamental Analysis
AbbVie Stock Info
Market Cap:
326.97B
Price in USD:
185.16
Share Volume:
6.93M
AbbVie 52-Week Range
52-Week High:
186.85
52-Week Low:
135.85
Buy
73
AbbVie (ABBV)
is a Buy
AbbVie Share Price Forecast
-
What is the AbbVie stock price today?
The AbbVie stock price is 185.16 USD today. -
Will ABBV stock go up or go down?
AbbVie> share price is forecast to RISE/FALL based on technical indicators -
Is AbbVie overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, AbbVie is not overvalued.
Is AbbVie Stock a Buy?
- AbbVie share price is 185.16 while ABBV 8-day exponential moving average is 177.16, which is a Buy signal.
- The stock price of ABBV is 185.16 while AbbVie 20-day EMA is 173.10, which makes it a Buy.
- AbbVie 50-day exponential moving average is 169.82 while ABBV share price is 185.16, making it a Buy technically.
- ABBV stock price is 185.16 and AbbVie 200-day simple moving average is 163.79, creating a Buy signal.
Fundamental Analysis of AbbVie
Is AbbVie a good investment?
- Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.28 per share, and an increase next year of $1.18 per share.
Technical Analysis of AbbVie
Should I short AbbVie stock?
- ABBV Moving Average Covergence Divergence (MACD) indicator is 3.25, suggesting AbbVie is a Buy
- AbbVie Relative Strength Index (RSI) is 72.04, which suggest AbbVie is overbought
- The Bollinger Bands (25) for AbbVie is (166.67 - 175.89), which suggest AbbVie is a Buy
- The Bollinger Bands (100) for AbbVie is (162.02 - 176.42), which suggest AbbVie is a Buy
* AbbVie stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.